- Home
- MNY vs AIDX Comparison
MNY vs AIDX Comparison
Compare MNY & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNY | AIDX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.1M | 58.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MNY | AIDX |
|---|---|---|
| Price | $1.44 | $2.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 45.0K | ★ 339.0K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.58 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $2.72 |
| 52 Week High | $2.40 | $14.09 |
Technical Indicators
Market Signals| Indicator | MNY | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.87 | 5.68 |
| Support Level | $1.31 | N/A |
| Resistance Level | $1.52 | N/A |
| Average True Range (ATR) | 0.06 | 1.39 |
| MACD | 0.00 | -0.42 |
| Stochastic Oscillator | 50.00 | 3.19 |
Price Performance
Historical ComparisonAbout MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.